BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23576573)

  • 1. SMARCB1/INI1 genetic inactivation is responsible for tumorigenic properties of epithelioid sarcoma cell line VAESBJ.
    Brenca M; Rossi S; Lorenzetto E; Piccinin E; Piccinin S; Rossi FM; Giuliano A; Dei Tos AP; Maestro R; Modena P
    Mol Cancer Ther; 2013 Jun; 12(6):1060-72. PubMed ID: 23576573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
    Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G
    Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic determinants in epithelioid sarcoma.
    Gasparini P; Facchinetti F; Boeri M; Lorenzetto E; Livio A; Gronchi A; Ferrari A; Massimino M; Spreafico F; Giangaspero F; Forni M; Maestro R; Alaggio R; Pilotti S; Collini P; Modena P; Sozzi G
    Eur J Cancer; 2011 Jan; 47(2):287-95. PubMed ID: 20932739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma.
    Papp G; Changchien YC; Péterfia B; Pecsenka L; Krausz T; Stricker TP; Khoor A; Donner L; Sápi Z
    Mod Pathol; 2013 Mar; 26(3):393-403. PubMed ID: 23174932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary epithelioid sarcoma of bone: report of a unique case, with immunohistochemical and fluorescent in situ hybridization confirmation of INI1 deletion.
    Raoux D; Péoc'h M; Pedeutour F; Vaunois B; Decouvelaere AV; Folpe AL
    Am J Surg Pathol; 2009 Jun; 33(6):954-8. PubMed ID: 19342946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases.
    Folpe AL; Schoolmeester JK; McCluggage WG; Sullivan LM; Castagna K; Ahrens WA; Oliva E; Biegel JA; Nielsen GP
    Am J Surg Pathol; 2015 Jun; 39(6):836-49. PubMed ID: 25651469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.
    Sullivan LM; Folpe AL; Pawel BR; Judkins AR; Biegel JA
    Mod Pathol; 2013 Mar; 26(3):385-92. PubMed ID: 23060122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma.
    Flucke U; Slootweg PJ; Mentzel T; Pauwels P; Hulsebos TJ
    Hum Pathol; 2009 Sep; 40(9):1361-2; author reply 1362-4. PubMed ID: 19683621
    [No Abstract]   [Full Text] [Related]  

  • 10. Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.
    Le Loarer F; Zhang L; Fletcher CD; Ribeiro A; Singer S; Italiano A; Neuville A; Houlier A; Chibon F; Coindre JM; Antonescu CR
    Genes Chromosomes Cancer; 2014 Jun; 53(6):475-86. PubMed ID: 24585572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Oshiro Y; Izumi T; Taguchi T; Tsuneyoshi M
    Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression.
    Kohashi K; Yamamoto H; Kumagai R; Yamada Y; Hotokebuchi Y; Taguchi T; Iwamoto Y; Oda Y
    Mod Pathol; 2014 Jun; 27(6):832-9. PubMed ID: 24287458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-articular epithelioid sarcoma showing mixed classic and proximal-type features: report of 2 cases, with immunohistochemical and molecular cytogenetic INI-1 study.
    Kosemehmetoglu K; Kaygusuz G; Bahrami A; Raimondi SC; Kilicarslan K; Yildiz Y; Folpe AL
    Am J Surg Pathol; 2011 Jun; 35(6):891-7. PubMed ID: 21566521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on Both mRNA and protein levels.
    Papp G; Krausz T; Stricker TP; Szendrői M; Sápi Z
    Genes Chromosomes Cancer; 2014 Feb; 53(2):168-76. PubMed ID: 24327545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of SMARCB1/INI1 protein in synovial sarcoma.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Matono H; Iwamoto Y; Taguchi T; Tsuneyoshi M
    Mod Pathol; 2010 Jul; 23(7):981-90. PubMed ID: 20305614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular genetics and immunophenotype of INI1/SMARCB in epithelioid sarcoma].
    Li L; Xia Q; Rao Q; Liu B; Wu B; Shi S; Yu B; Zhang R; Lu Z; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):389-93. PubMed ID: 25208989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
    Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
    Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining EGFR and mTOR blockade for the treatment of epithelioid sarcoma.
    Xie X; Ghadimi MP; Young ED; Belousov R; Zhu QS; Liu J; Lopez G; Colombo C; Peng T; Reynoso D; Hornick JL; Lazar AJ; Lev D
    Clin Cancer Res; 2011 Sep; 17(18):5901-12. PubMed ID: 21821699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile Epithelioid Sarcoma with Genomic Segmental Amplification of
    Srinivasan A; Liu M; Parham D; Li M; Wang X; Lu X; Li S; Zhang L; Yu Z
    Fetal Pediatr Pathol; 2020 Feb; 39(1):51-61. PubMed ID: 31215292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.